Patents by Inventor Nadia Naffakh

Nadia Naffakh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chicken RNA polymerase I promoter and the use thereof
    Patent number: 7935807
    Abstract: The invention relates to a novel polynucleotide exhibiting a promoting transcription activity, polynucleotide-containing vectors and to the use thereof for the transcription of interesting sequences such as the production of non-cap RNA virus. Said invention also relates to host cells preferably of avian origin, containing a polynucleotide or the inventive vector.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: May 3, 2011
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique (SNRS), Universite Paris 7-Denis Diderot
    Inventors: Nadia Naffakh, Pascale Massin, Sylvie Van Der Werf
  • Chicken rna polymerase i promoter and the use thereof
    Publication number: 20070134270
    Abstract: The invention relates to a novel polynucleotide exhibiting a promoting transcription activity, polynucleotide-containing vectors and to the use thereof for the transcription of interesting sequences such as the production of non-cap RNA virus. Said invention also relates to host cells preferably of avian origin, containing a polynucleotide or the inventive vector.
    Type: Application
    Filed: February 27, 2004
    Publication date: June 14, 2007
    Inventors: Nadia Naffakh, Pascale Massin, Sylvie Van Der Werf
  • RECOMBINANT SEGMENTED NEGATIVE STRAND VIRUS CONTAINING BICISTRONIC VRNA SEGMENT WITH A DUPLICATION OF ITS 3? NONCODING FLANKING SEQUENCE, AND VACCINES AND THERAPEUTIC COMPOSITIONS CONTAINING THE SAME
    Patent number: 6723559
    Abstract: The present invention relates to recombinant negative strand RNA molecules which may be used to express heterologous proteins in animal cells and/or to construct recombinant viruses able to express heterologous proteins during their multiplication in host animal cells.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: April 20, 2004
    Assignee: Institute Pasteur
    Inventors: Nicolas Robert Xavier Escriou, Sylvie Van Der Werf, Alexandre Vieira-Machado, Nadia Naffakh
  • Recombinant segmented negative strand virus containing bicistronic vRNA segment with a duplication of its 3' noncoding flanking sequence, and vaccines and therapeutic compositions containing the same
    Publication number: 20030008277
    Abstract: The present invention relates to recombinant negative strand RNA molecules which may be used to express heterologous proteins in animal cells and/or to construct recombinant viruses able to express heterologous proteins during their multiplication in host animal cells.
    Type: Application
    Filed: April 17, 2002
    Publication date: January 9, 2003
    Applicant: INSTITUTE PASTEUR
    Inventors: Nicolas Robert Xavier Escriou, Sylvie Van Der Werf, Alexandre Vieira-Machado, Nadia Naffakh
  • Composition for the in vivo production of therapeutic products
    Patent number: 6464998
    Abstract: The present invention provides cell compositions for in vivo implantation, and designed for the sustained and controlled delivery of therapeutic substances.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: October 15, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Yves Beuzard, Olivier Danos, Vincent Descamps, Jean-Michel Heard, Philippe Moullier, Nadia Naffakh, Michel Perricaudet, William Vainchenker